HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Azurel IPO will help finance Private Label, Scents Overnight acquisitions.

This article was originally published in The Rose Sheet

Executive Summary

AZUREL IPO WILL HELP FINANCE PRIVATE LABEL GROUP ACQUISITION: start-up company Azurel purchased the four subsidiaries that make up the Pri-vate Label Group for approximately $2.8 mil. on Aug. 22, according to Azurel's Oct. 30 preliminary prospectus for an initial public offering. Manhattan-based Azurel paid $131,250 in cash at the close of the Private Label deal, with delivery of a $1.8 mil. promissory note. The remaining $892,500 will be paid after the IPO closes in the form of common stock valued at the public offering price, the prospectus states.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003437

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel